The Need for Academic Leadership in Full-Spectrum Translational Research

Clinical and Translational Science

Volumn 4, Issue 2, 2011, Pages 78-79

  Selker, Harry P ^a,b   Califf, Robert M ^c,d  

^a Society for Clinical and Translational Science   (United States)

^b TUFTS UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d Clinical Research Forum   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INVESTMENT; LEADERSHIP; NOTE; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH; UNITED STATES;

CLINICAL TRIALS AS TOPIC; FACULTY; FEDERAL GOVERNMENT; HUMANS; LEADERSHIP; NATIONAL INSTITUTES OF HEALTH (U.S.); PATIENT ADVOCACY; RESEARCH SUPPORT AS TOPIC; TRANSLATIONAL RESEARCH; UNITED STATES; UNIVERSITIES;

EID: 79953301140     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00275.x     Document Type: Note

References (3)

1. Ioannidis JP. Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Translat Med. Jan 31 2004; 2(1): 5.
2. Crimmins EM, Preston SH, Cohen B, Editors. Panel on Understanding Divergent Trends in Longevity in High-Income Countries; National Research Council
3. DeMets DL, Califf RM. A historical perspective on clinical trials innovation and leadership: where have the academics gone JAMA. Feb 16 2011; 305(7): 713-714.